← Eichor
Study identifier: NCT06303622 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial

Condition: Prostate Cancer  ·  Sponsor: Chinese University of Hong Kong

PhaseNA
Planned participants1250
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is an international multicentre RCT to compare the linically significant prostate cancer (csPCa) detection of cognitive-guided and MRI-USG guided biopsies in men with suspicious MRI lesion.

This description comes directly from the study's public registry record.

Talk to the study team

Peter Ka-Fungq CHIU, PhD  ·  35052625  ·  peterchiu@surgery.cuhk.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Prince of Wales HospitalHong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06303622